Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 301–400 of 1,009
SILAC Analysis Reveals Increased Secretion of Hemostasis-Related Factors by Senescent Cells
Wiley, C. D., Liu, S., Limbad, C., Zawadzka, A. M., Beck, J., Demaria, M., Artwood, R., Alimirah, F., Lopez-Dominguez, J.-A., Kuehnemann, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.049 · Cited by 137
Stauffer, J. K., Scarzello, A. J., Jiang, Q., & Wiltrout, R. H. (2012) · Hepatology · doi:10.1002/hep.25674 · Cited by 135
“In liver, (oncogene-induced) senescent hepatocytes also secrete CTACK, IL-1a, leptin/leptin R, MCP1, and RANTES.(19) Noninitiated bystander cells including immune cells can reinforce this program by also secreting prosenescent cytokines.”
InfluentialBrenner, E., Schörg, B. F., Ahmetlić, F., Wieder, T., Hilke, F. J., Simon, N., Schroeder, C., Demidov, G. M., Riedel, T., Fehrenbacher, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14987-6 · Cited by 147
Self-citationCD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human Cancer
Kortekaas, K. E., Santegoets, S. J. A. M., Sturm, G., Ehsan, I., van Egmond, S. L., Finotello, F., Trajanoski, Z., Welters, M. J. P., van Poelgeest, M. I. E., & van der Burg, S. H. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0270 · Cited by 150
Colucci, M., Sarill, M., Maddalena, M., Valdata, A., Troiani, M., Massarotti, M., Bolis, M., Bressan, S., Kohl, A., Robesti, D., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.015 · Cited by 164
Lesina, M., Wörmann, S. M., Morton, J., Diakopoulos, K. N., Korneeva, O., Wimmer, M., Einwächter, H., Sperveslage, J., Demir, I. E., Kehl, T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86477 · Cited by 128
“Further, SASP is known to contribute to the surveillance and elimination of senescent cells through a tumor-suppressive immune response during the early stages of tumorigenesis (20, 21).”
BackgroundSenescent cells: Living or dying is a matter of NK cells
Antonangeli, F., Zingoni, A., Soriani, A., & Santoni, A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-299r · Cited by 129
Intermittent hypoxia induces a metastatic phenotype in breast cancer
Chen, A., Sceneay, J., Gödde, N., Kinwel, T., Ham, S., Thompson, E. W., Humbert, P. O., & Möller, A. (2018) · Oncogene · doi:10.1038/s41388-018-0259-3 · Cited by 133
The Impact of Immune System Aging on Infectious Diseases
Quiros-Roldan, E., Sottini, A., Natali, P. G., & Imberti, L. (2024) · Microorganisms · doi:10.3390/microorganisms12040775 · Cited by 133
“Infected patients likely produce an increased number of intrahepatic senescent, not functional T cells [156,157], which may promote the development of hepatocellular cancer as these T cells would be unable to eliminate premalignant senescent hepatocytes [158].”
Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1
Xiao, G., Deng, A., Liu, H., Ge, G., & Liu, X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206370109 · Cited by 131
“I a process known as tumor immunosurveillance, effector T cells, in cooperation with other immune cells, can recognize and destroy premalignant somatic cells in the initial stages of tumor development (1).”
BackgroundBiology of Cancer and Aging: A Complex Association With Cellular Senescence
Falandry, C., Bonnefoy, M., Freyer, G., & Gilson, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1432 · Cited by 128
Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
Salam, R., Saliou, A., Bielle, F., Bertrand, M., Antoniewski, C., Carpentier, C., Alentorn, A., Capelle, L., Sanson, M., Huillard, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36124-9 · Cited by 132
Calcium signaling and cellular senescence
Martin, N., & Bernard, D. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.04.001 · Cited by 140
Upregulation of PD-L1 in Senescence and Aging
Onorati, A., Havas, A. P., Lin, B., Rajagopal, J., Sen, P., Adams, P. D., & Dou, Z. (2022) · Molecular and Cellular Biology · doi:10.1128/mcb.00171-22 · Cited by 129
“Mice lacking T-cells exhibited impaired ability to remove senescent cells (68).”
BackgroundGonzalez-Meljem, J. M., Haston, S., Carreno, G., Apps, J. R., Pozzi, S., Stache, C., Kaushal, G., Virasami, A., Panousopoulos, L., Mousavy-Gharavy, S. N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01992-5 · Cited by 130
Self-citationBrown, G. C. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00921-6 · Cited by 129
“Clearance of senescent cancer cells from the body also can limit cancer development 138 .”
Targeting Senescent Cells for a Healthier Aging: Challenges and Opportunities
Song, S., Tchkonia, T., Jiang, J., Kirkland, J. L., & Sun, Y. (2020) · Advanced Science · doi:10.1002/advs.202002611 · Cited by 129
Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
Arvanitakis, K., Κoletsa, T., Mitroulis, I., & Germanidis, G. S. (2022) · Cancers · doi:10.3390/cancers14010226 · Cited by 145
“However, they can also participate in tumor immune surveillance and antitumor responses [28,29].”
BackgroundCellular senescence in lung cancer: Molecular mechanisms and therapeutic interventions
Jha, S. K., Rubis, G. D., Devkota, S. R., Zhang, Y., Adhikari, R., Jha, L. A., Bhattacharya, K., Mehndiratta, S., Gupta, G., Singh, S. K., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102315 · Cited by 151
“For instance, in mice, macrophages are recruited by the release of CCL2 and then activated with the support of CD4 + T cells (Kang et al., 2011; Regis et al., 2009).”
Mossanen, J. C., Kohlhepp, M., Wehr, A., Krenkel, O., Liepelt, A., Roeth, A. A., Möckel, D., Heymann, F., Lammers, T., Gassler, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.247 · Cited by 125
Self-citationHBV induced hepatocellular carcinoma and related potential immunotherapy
Jia, L., Gao, Y., He, Y., Hooper, J. D., & Yang, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104992 · Cited by 140
Pluripotent stem cells escape from senescence-associated DNA methylation changes
Koch, C. M., Reck, K., Shao, K., Lin, Q., Joussen, S., Ziegler, P., Walenda, G., Drescher, W., Opalka, B., May, T., et al. (2013) · Genome Research · doi:10.1101/gr.141945.112 · Cited by 121
“In addition, it has been speculated that long-term cultureassociated changes are related to a developmental process that might be functionally relevant for suppressing tumorigenesis in vivo (Campisi and d’Adda di 2007; Kang et al. 2011).”
BackgroundSenolytics for Cancer Therapy: Is All that Glitters Really Gold?
Carpenter, V. J., Saleh, T., & Gewirtz, D. A. (2021) · Cancers · doi:10.3390/cancers13040723 · Cited by 124
DDR-mediated crosstalk between DNA-damaged cells and their microenvironment
Malaquin, N., Carrier-Leclerc, A., Dessureault, M., & Rodier, F. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00094 · Cited by 113
“MINI REVIEW published: 12 March 2015 doi: 10.3389/fgene.2015.00094 Edited by: Antonio Porro, University of Zurich, Switzerland Reviewed by: David Raulet, University of California, Berkeley, USA Alessandra Montecucco,”
BackgroundInfluentialCenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
Tacke, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442436 · Cited by 121
“senescent, pre-malignant hepatocytes and activate macrophages for the clearance of these tumor precursors [72, 73, 74].”
BackgroundSelf-citationCellular senescence: a double-edged sword in cancer therapy
Xiao, S., Qin, D., Hou, X., Tian, L., Yu, Y., Zhang, R., Lyu, H., Guo, D. S., Chen, X., Zhou, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1189015 · Cited by 144
“These factors damage the DNA of neighboring cells and increase the expression of p16, p21, and IL-8, thereby inducing senescence of adjacent cells (41).”
BackgroundBelle, J. I., Sen, D., Baer, J. M., Liu, X., Lander, V. E., Ye, J., Sells, B. E., Knolhoff, B. L., Ahmad, F. F., Kang, L., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0428 · Cited by 137
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
Kolesnichenko, M., Hong, L., Liao, R., Vogt, P. K., & Sun, P. (2012) · Cell Cycle · doi:10.4161/cc.20683 · Cited by 123
“Recent studies demonstrate the presence of oncogene-induced senescence in vivo; abrogation of the senescence response leads to development of hepatocellular carcinoma in mice.(1) Mechanisms that disrupt senescence in either damaged cells or pre-malignant cells could lead to oncogenic transformation.”
BackgroundCirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma
Garrido, A., & Djouder, N. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.08.005 · Cited by 134
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
“In addition to reinforcing senescence, SASP can also activate immune surveillance, which has been demonstrated in a mosaic mouse model for hepatocellular carcinoma (Xue et al., 2007; Kang et al., 2011).”
BackgroundInfluentialLi, L., Xiang, T., Guo, J., Guo, F., Wu, Y., Feng, H., Liu, J., Tao, S., Fu, P., & Ma, L. (2024) · Nature Communications · doi:10.1038/s41467-024-47315-3 · Cited by 111
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
“Moreover, lastingly arrested cells may be lost in vivo due to immune clearance, thereby further complicating the assessment of senescence stability (Chen et al., 2023a; Eggert et al., 2016; Kang et al., 2011; Marin et al., 2023; Reimann et al., 2021; Xue et al., 2007).”
BackgroundTranscriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer
Ostroumov, D., Duong, S., Wingerath, J., Woller, N., Manns, M. P., Timrott, K., Kleine, M., Ramackers, W., Roessler, S. K., Nahnsen, S., et al. (2021) · Hepatology · doi:10.1002/hep.31466 · Cited by 132
Self-citationStressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
Lau, L., Porciuncula, A., Yu, A., Iwakura, Y., & David, G. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00586-18 · Cited by 119
Of Flies, Mice, and Men: Evolutionarily Conserved Tissue Damage Responses and Aging
Neves, J., Demaria, M., Campisi, J., & Jasper, H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.11.028 · Cited by 118
“Several groups reported involvement of the Hpo pathway in initiating paracrine Upd and EGF-like signaling (Karpowicz et al., 2010; Ren et al., 2010; Shaw et al., 2010).”
BackgroundLunyak, V. V., Amaro-Ortiz, A., & Gaur, M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00220 · Cited by 114
“The resident macrophages (Kupffer cells) in the liver have been shown to take no blame in the elimination of Nras G12V -expressing senescent hepatocytes (Kang et al., 2011).”
BackgroundInfluentialDagher, O., Mury, P., Thorin‐Trescases, N., Noly, P., Thorin, É., & Carrier, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.658400 · Cited by 126
“In an elegant and seminal experiment, Baker et al. demonstrated that the health span in progeroid mice can be enhanced by killing SCs using a transgenic suicide gene (188).”
BackgroundInfluentialCell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
“However, the malfunctioning or escape of this senescent surveillance can result in the survival of these cells, which can further replicate leading to the development of HCC 53,54 .”
InfluentialOncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
Comprehensive transcriptional landscape of aging mouse liver
White, R. R., Milholland, B., MacRae, S. L., Lin, M., Zheng, D., & Vijg, J. (2015) · BMC Genomics · doi:10.1186/s12864-015-2061-8 · Cited by 113
“Conversely, it has also been shown that infiltrating immune cells can clear pre-oncogenic senescent hepatocytes [43], thereby the same secretory phenotype emitted by cells to promote cancer can also act a barrier to tumorigenesis in the liver.”
BackgroundHit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
Saunderson, E. A., Stepper, P., Gomm, J. J., Hoa, L., Morgan, A., Allen, M. D., Jones, J. L., Gribben, J. G., Jurkowski, T. P., & Ficz, G. (2017) · Nature Communications · doi:10.1038/s41467-017-01078-2 · Cited by 113
Senescent cells and macrophages: key players for regeneration?
Elder, S. S., & Emmerson, E. (2020) · Open Biology · doi:10.1098/rsob.200309 · Cited by 120
The DNA Damage Response and Inflammation in Cancer
Klapp, V., Álvarez-Abril, B., Leuzzi, G., Kroemer, G., Ciccia, A., & Galluzzi, L. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1220 · Cited by 123
Tabariès, S., Ouellet, V., Hsu, B. E., Annis, M. G., Rose, A. A., Meunier, L., Carmona, E., Tam, C. E., Mes-Masson, A.-M., & Siegel, P. M. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0558-3 · Cited by 114
“widely and extensively used in the literature to deplete neutrophils [21,49,55-59].”
BackgroundSenescent Cells and Their Secretory Phenotype as Targets for Cancer Therapy
Velarde, M. C., Demaria, M., & Campisi, J. (2013) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000343572 · Cited by 112
The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype
Wallis, R., Mizen, H., & Bishop, C. L. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111263 · Cited by 108
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 119
Self-citationDetecting and targeting senescent cells using molecularly imprinted nanoparticles
Ekpenyong-Akiba, A. E., Canfarotta, F., Abd H., B., Poblocka, M., Casulleras, M., Castilla-Vallmanya, L., Kocsis-Fodor, G., Kelly, M. E., Janus, J., Althubiti, M., et al. (2019) · Nanoscale Horizons · doi:10.1039/c8nh00473k · Cited by 108
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 105
Self-citationCombinatorial approach to cancer immunotherapy: strength in numbers
Vilgelm, A. E., Johnson, D. B., & Richmond, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ri0116-013rr · Cited by 105
“described as the SASP [174, 175], which has been shown to attract cells of the innate and adaptive immune system that kill and clear senescent cells [176, 177].”
BackgroundQin, X., Suzuki, H., Honda, M., Okada, H., Kaneko, S., Inoue, I., Ebisui, E., Hashimoto, K., Carninci, P., Kanki, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802279115 · Cited by 115
“Intriguingly, in animal models of NASH, the accumulation of linoleic acid in hepatocytes caused the selective loss of intrahepatic CD4 T lymphocytes (5), suggesting that they are a link between lipid dysregulation and liver carcinogenesis that involves the impairment of antitumor surveillance (4).”
BackgroundTransmitting senescence to the cell neighbourhood
Hoare, M., & Narita, M. (2013) · Nature Cell Biology · doi:10.1038/ncb2811 · Cited by 108
To clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · BioEssays · doi:10.1002/bies.201670910 · Cited by 108
White, R. R., Milholland, B., de Bruin, A., Curran, S., Laberge, R.-M., van Steeg, H., Campisi, J., Maslov, A. Y., & Vijg, J. (2015) · Nature Communications · doi:10.1038/ncomms7790 · Cited by 107
“Alternatively, the reduction in p21 two months after DSB induction may reflect the clearance of pre-malignant senescent hepatocytes by the immune system 57 .”
Ye, Y., Zhao, J., Lu, Y., Gao, C.-C., Yang, Y., Liang, S.-Q., Lu, Y., Wang, L., Yue, S., Dou, K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1691 · Cited by 110
Lin, H., Yan, J., Wang, Z., Hua, F., Yu, J., Sun, W., Li, K., Liu, H., Yang, H., Lv, Q., et al. (2013) · Hepatology · doi:10.1002/hep.25991 · Cited by 103
“This pathway has been shown to play a critical role in stress- or oncogene-induced premature cellular senescence.(20,21) Interestingly, the expression of p53, an alternative trigger of cellular senescence, was induced in the sham- or DEN-treated TLR2 / livers (Fig.”
BackgroundNelson, D. M., Jaber-Hijazi, F., Cole, J. J., Robertson, N. A., Pawlikowski, J. S., Norris, K. T., Criscione, S. W., Pchelintsev, N. A., Piscitello, D., Stong, N., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1017-x · Cited by 106
Biological functions of therapy-induced senescence in cancer
Fitsiou, E., Soto-Gamez, A., & Demaria, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.021 · Cited by 111
Liu, Y., Hawkins, O. E., Su, Y., Vilgelm, A. E., Sobolik, T., Thu, Y., Kantrow, S., Splittgerber, R. C., Short, S., Amiri, K. I., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201378 · Cited by 99
“A recent study showed that immune surveillance of senescent pre-malignant hepatocytes, as mediated by macrophages and T cells, limits tumour formation (Kang et al, 2011).”
Wiggins, K. A., Parry, A. J., Cassidy, L. D., Humphry, M., Webster, S. J., Goodall, J. C., Narita, M., & Clarke, M. C. H. (2019) · Aging Cell · doi:10.1111/acel.12946 · Cited by 104
“IL‐1 also drives homeostatic processes such as thermoregulation (Dinarello, 2009), regulatory B‐cell differentiation (Rosser et al., 2014), intestinal integrity (Jung et al., 2015), and the immune surveillance and clearance of senescence cells (Kang et al., 2011).”
Constitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence
Angelini, P. D., Fluck, M. F. Z., Pedersen, K., Parra-Palau, J. L., Guiu, M., Bernadó Morales, C., Vicario, R., Luque-García, A., Navalpotro, N. P., Giralt, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2301 · Cited by 100
“Using immunocompetent mice, a recent report shows that the adaptive immune system rapidly clears Ras-induced hepatocarcinoma senescent cells from early tumor lesions (8).”
BackgroundRegulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging
Kato, K., Logsdon, N. J., Shin, Y.-J., Palumbo, S., Knox, A., Irish, J. D., Rounseville, S. P., Rummel, S. R., Mohamed, M., Ahmad, K., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0092oc · Cited by 114
“For example, in response to stress-induced oncogene activation, induction of cellular senescence serves as a critical barrier against tumor development (46), which prevents proliferation and ultimately the transmission of deleterious mutations (24).”
BackgroundAssouline, B., Kahn, R., Hodali, L., Condiotti, R., Engel, Y., Elyada, E., Mordechay‐Heyn, T., Pitarresi, J. R., Atias, D., Steinberg, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50441-7 · Cited by 110
Genome amplification and cellular senescence are hallmarks of human placenta development
Velicky, P., Meinhardt, G., Plessl, K., Vondra, S., Weiss, T., Haslinger, P., Lendl, T., Aumayr, K., Mairhofer, M., Zhu, X., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007698 · Cited by 102
Toshima, T., Shirabe, K., Fukuhara, T., Ikegami, T., Yoshizumi, T., Soejima, Y., Ikeda, T., Okano, S., & Maehara, Y. (2014) · Hepatology · doi:10.1002/hep.27140 · Cited by 100
“In particular, it is unknown whether induction of autophagy is involved in the induction of senescence or vice versa.(26,27) The results of our study suggest that autophagy regulates cellular senescence during liver regeneration.”
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Radiotherapy modulates tumor cell fate decisions: a review
Chen, H., Han, Z., Luo, Q., Wang, Y., Li, Q., Zhou, L., & Zuo, H.-D. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02171-7 · Cited by 110
“However, in the later stages of RT, the accumulation of senescent cells may adversely affect prognosis, as the immune microenvironment generated by SASP may promote tumor recurrence [101, 106] The high recurrence rate of some cancers after RT may be related to the accumulation of Fig.”
BackgroundC/EBPγ Suppresses Senescence and Inflammatory Gene Expression by Heterodimerizing with C/EBPβ
Huggins, C. J., Malik, R., Lee, S., Salotti, J., Thomas, S., Martin, N., Quiñones, O. A., Alvord, W. G., Olanich, M. E., Keller, J. R., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01674-12 · Cited by 102
“(5) recently reported that “senescence surveillance” by a T-cell-mediated adaptive immune response is required for efficient suppression of oncogenic N-ras-induced liver tumorigenesis in mice through removal of premalignant cells.”
BackgroundHepatic senescence, the good and the bad
Huda, N., Liu, G., Hong, H., Yan, S., Khambu, B., & Yin, X.-M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5069 · Cited by 100
Liu, H., Zhao, H., & Sun, Y. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.004 · Cited by 109
Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging
Han, X., Lei, Q., Xie, J., Liu, H., Li, J., Zhang, X., Zhang, T., & Gou, X. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac097 · Cited by 112
Fang, Q., Stehr, A. M., Naschberger, E., Knopf, J., i, M. H., & Stürzl, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1075260 · Cited by 114
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
Wirth, T. C., & Kühnel, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01848 · Cited by 98
“Even premalignant senescent cells are detected and cleared by a process that involves both macrophages and CD4 cells (16).”
BackgroundKarabicici, M., Alptekin, S., Karagonlar, Z. F., & Erdal, E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12916 · Cited by 104
Rajapakse, J., Khatiwada, S., Akon, A. C., Yu, K. L., Shen, S., & Zekry, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2240031 · Cited by 102
“Further, as liver disease progresses and in the context of a dysbiotic environment, senescence surveillance of pre-malignant hepatocytes by T cells becomes impaired.(41) Impaired immunosurveillance combined with an immunosuppressive milieu sets the liver microenvironment for cancer formation and progression.”
BackgroundSoriani, A., Iannitto, M. L., Ricci, B., Fionda, C., Malgarini, G., Morrone, S., Peruzzi, G., Ricciardi, M. R., Petrucci, M. T., Cippitelli, M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400271 · Cited by 104
Cellular senescence: from growth arrest to immunogenic conversion
Burton, D. G. A., & Faragher, R. (2015) · AGE · doi:10.1007/s11357-015-9764-2 · Cited by 112
“In addition to NK cells, T-cells and macrophages also appear to play a role in immunosurveillance of senescent cells.”
BackgroundInfluentialCellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Self-citation(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“While chronic in fl ammation can contribute to hepatocarcinogenesis, the immune system also plays a key role in restraining the development of HCC by removing senescent and transformed hepatocytes and cancer cells [143 – 145].”
Hubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 105
Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
Irvine, K. M., Skoien, R., Bokil, N. J., Melino, M., Thomas, G. P., Loo, D., Gabrielli, B., Hill, M. M., Sweet, M. J., Clouston, A. D., et al. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17851 · Cited by 97
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96
Self-citationExtremely Differentiated T Cell Subsets Contribute to Tissue Deterioration During Aging
Soto‐Heredero, G., Heras, M. M. G. D. L., Escrig-Larena, J. I., & Mittelbrunn, M. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-064501 · Cited by 104
Zhang, F., Guo, J., Yu, S., Zheng, Y., Duan, M., Zhao, L., Wang, Y., Yang, Z., & Jiang, X. (2024) · 癌症:英文版 · doi:10.1002/cac2.12591 · Cited by 112
“Precan-cerous senescent hepatocytes rely on the adaptive immune response mediated by T cells, monocytes, and macrophages to regulate the immunological clearance of senescent cells through release of inflammatory factors [301].”
BackgroundCOX2 regulates senescence secretome composition and senescence surveillance through PGE2
Gonçalves, S., Yin, K., Ito, Y., Chan, A., Olan, I., Gough, S., Cassidy, L., Serrao, E., Smith, S., Young, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108860 · Cited by 95
“…elements containing oncogenic NRASG12V leads to hepatocyte RIS in 6 days, with a subsequent CD4+ T-lymphocyte- and macrophage-dependent immune reaction (Eggert et al., 2016; Kang et al., 2011), driving clearance of RIS hepatocytes from days (D) 6 to 12 post-HDTV injection (Hoare et al., 2016).”
BackgroundMethodInfluentialCancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 90
The role of senescence in cancer development
Mavrogonatou, E., Pratsinis, H., & Kletsas, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.06.018 · Cited by 105
Wang, C., Cigliano, A., Delogu, S., Armbruster, J., Dombrowski, F., Evert, M., Chen, X., & Calvisi, D. F. (2013) · Cell Cycle · doi:10.4161/cc.25099 · Cited by 96
Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail
Moon, H., Ju, H.-L., Chung, S. I., Cho, K. J., Eun, J. W., Nam, S. W., Han, K.-H., Calvisi, D. F., & Ro, S. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.014 · Cited by 92
Paffenholz, S. V., Salvagno, C., Ho, Y.-J., Limjoco, M., Baslan, T., Tian, S., Kulick, A. R., de Stanchina, E., Wilkinson, J. E., Barriga, F. M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117754119 · Cited by 96
“The SASP alters the tumor microenvironment (TME), where it can modulate extracellular matrix, tumor vasculature, and the functionality of immune cells (42, 43) that, in some instances, produces an inflammatory TME (44, 45).”
BackgroundElyahu, Y., & Monsonego, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101231 · Cited by 103
“Integrated with the innate arm of the immune system, T cells provide protection against pathogens and orchestrate tissue maintenance and repair, such as wound-healing processes and clearance of cancer and senescent cells in a regulated fashion, which prevents destructive autoimmunity and inflammation (Kang et al., 201…”
BackgroundA non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence
Cheng, Y., Wang, S., Zhang, H., Lee, J.-S., Ni, C., Guo, J., Chen, E., Wang, S., Acharya, A., Chang, T.-C., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.019 · Cited by 98
“66,67 Hydro-dynamic transfection (HDT) was used to deliver plasmids encoding (1) a Sleeping Beauty transposon carrying oncogenic NRAS (NRAS G12V ); (2) Sleeping Beauty transposase; and (3) Cas9 along with control or SNORA13-targeting sgRNAs to mouse livers (Figure 7C).”
Gao, Y., He, Z., Zhou, X., Xian, L., Yuan, T.-Z., Jia, X., Hong, J., He, L., & Liu, J. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2077 · Cited by 97
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
The Role of Myeloid-Derived Cells in the Progression of Liver Disease
Weston, C. J., Zimmermann, H. W., & Adams, D. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00893 · Cited by 95
“In the context of liver carcinogenesis monocytes/macrophages exert dualistic functions in a stage-dependent manner with CCR2 CCL2-responsive monocytes promoting tumor surveillance through the elimination of senescent premalignant hepatocytes in healthy livers (Figure 4), whereas in established tumors monocytes/macroph…”
BackgroundRole of chemokine pathways in hepatobiliary cancer
Ehling, J., & Tacke, F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.017 · Cited by 94
Self-citationFaggioli, F., Palagano, E., Di Tommaso, L., Donadon, M., Marrella, V., Recordati, C., Mantero, S., Villa, A., Vezzoni, P., & Cassani, B. (2018) · Hepatology · doi:10.1002/hep.29636 · Cited by 90
“In fact, CD4(1) T lymphocytes can either induce growth arrest and senescence in cancer cells by secreting proinflammatory cytokines or trigger the clearance of senescent premalignant hepatocytes.((9-11)) Interestingly, a role for B cells in the pathogenesis of liver fibrosis (LF) has been also hypothesized.”
Background
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.